Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
Market Access and Evidence Generation Strategies At every stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s value . For clinical and commercial teams alike, we provide …
15th European Public Health Conference 2022 (EPH) Share on: Wednesday, November 9 - Saturday, November 12, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 15th European Public Health Conference …
… Solutions and Lundbeck conducted a systematic literature review to identify published utility values capturing … receiving pharmacological intervention. For new MDD therapies to gain reimbursement approval, pharmaceutical … pharmacological interventions: a systematic literature review . Brockbank J , Krause T, Moss E , Pedersen AM, Morup …
… to improve coverage and pricing potential? Literature Review What lessons from existing studies can be applied to …
… Multi-Criteria Decision Analysis Most drug development and commercialization choices are complex. … Market Access and Post-Approval Decisions From making drug development decisions, to phase III evidence plans, to …
… using their treatment for advanced or metastatic breast cancer in a US real-world setting. While there was a broad …
… Solutions FDA Guidance In June 2018, the United States Food and Drug Administration (US FDA) released an important guidance … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; …
… developed elsewhere, including: Targeted review of burden of illness Systematic reviews of clinical …
… Surgery Annual Meeting. Patients' willingness to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin cancer. Skelsey MK, Okun MM, Schiro J, Dozier S, Glinert R, …
… ESMO 24th World Congress on Gastrointestinal Cancer Share on: Wednesday, June 29 - Sunday, July 3, 2022 … at the ESMO 24th World Congress on Gastrointestinal Cancer. Patient preferences for unresectable hepatocellular …